CONTEGIACOMO, ALMA
 Distribuzione geografica
Continente #
EU - Europa 472
NA - Nord America 469
AS - Asia 70
Totale 1011
Nazione #
US - Stati Uniti d'America 443
IT - Italia 232
UA - Ucraina 105
CN - Cina 65
NL - Olanda 48
DE - Germania 30
CA - Canada 26
FI - Finlandia 25
FR - Francia 14
IE - Irlanda 10
GB - Regno Unito 8
IN - India 3
VN - Vietnam 2
Totale 1011
Città #
Chandler 78
Jacksonville 76
Amsterdam 48
Millbury 32
Napoli 30
Princeton 27
Ottawa 24
Nanjing 16
Beijing 15
Wilmington 13
Boston 9
Milan 7
Shenyang 7
Changsha 6
Rozzano 6
Thiene 6
Ann Arbor 5
Nanchang 5
Dublin 4
Menfi 4
Norwalk 4
Rome 4
Salerno 4
Tianjin 4
Augusta 3
Falls Church 3
Hebei 3
Leawood 3
Redwood City 3
Serravalle Scrivia 3
Villaricca 3
Ariano Irpino 2
Borgomanero 2
Castellammare Di Stabia 2
Des Moines 2
Hanoi 2
Heidelberg 2
Jinan 2
Kunming 2
Latina 2
Mariano Comense 2
Mugnano Di Napoli 2
Nola 2
Orange 2
Piove Di Sacco 2
Rapolla 2
San Mateo 2
Scafati 2
Suri 2
Toronto 2
Andover 1
Arzano 1
Aversa 1
Bari 1
Benevento 1
Bozen 1
Caivano 1
Calvizzano 1
Capena 1
Castelvetrano 1
Catania 1
Cesano 1
Cesenatico 1
Duncan 1
Fairfield 1
Frattamaggiore 1
Genoa 1
Genova 1
Giugliano In Campania 1
Gragnano 1
Hangzhou 1
Indiana 1
Jiaxing 1
Lanzhou 1
Lauro 1
Lecce 1
Leeds 1
Marigliano 1
Mezzolombardo 1
Mumbai 1
Naples 1
Ningbo 1
Nocera Inferiore 1
Nutley 1
Ottaviano 1
Pavia 1
Pomigliano D'arco 1
Portici 1
Porto Sant'elpidio 1
Pozzuoli 1
Rimini 1
Roccadaspide 1
Santa Maria A Vico 1
Sessa Cilento 1
Simi Valley 1
Taizhou 1
Torino 1
Torre Annunziata 1
Villarosa 1
Walnut 1
Totale 543
Nome #
null 223
Manuale di Oncologia Clinica 88
null 67
Counseling e Consenso Informato 39
CAVBP-DEP Altemative Chemotherapy for the treatment of intermediate and high grade non Hodgkin lymphoma: final results of a pilot study. 35
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. 32
Italian Network for Hereditary Familial Breast/Ovarian Cancer: frequency of associated tumours 31
p53 expression is decreased in primary breast carcinomas with microsatellite instability. 30
Melanoma 30
Changing presentation in non Hodgkin lymphoma". 29
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling 29
Multiparametric bio-pathological analysis of hereditary and familial breast cancer 28
Melanoma Maligno: Integrazione tra oncologo e dermatologo nella identificazione di forme eredo-familiari 28
Malingnant Melanoma Clustering with some familial/hereditary tumors 27
Malignant melanoma Clustering with some familial/hereditary tumors 27
Carcinoma del polmone 26
The cancer spectrum related to hereditary and familial breast and ovarian cancers 26
The Italian Multi-Centre Project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 25
Altre Neoplasie 25
Individuazione dei soggetti a rishio di carcinoma della prostata eredo-familiare 25
Retrospective Analysis of Familial Clustering for Malignant Melanoma 25
Interazione tumore-trattamento-paziente 24
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen. 23
Retrospective analysis of familial clustering for malignant melanoma 22
Irradiation of the hypothalamic - hypophyseal area induces complete remission of mucocutaneous lesions in disseminated Histiocytosis X: a case report. 19
Core curriculum. Oncologia clinica 18
The treatment of metastatic pleural effusion in breast cancer: report of 25 cases. 16
Core curriculum. Oncologia clinica 15
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy. 14
Totale 1046
Categoria #
all - tutte 2117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201813 0000 00 00 00013
2018/2019129 1810115 132 231 11089
2019/2020176 348213 184 52 1162341
2020/2021220 14201730 2523 264 302272
2021/2022162 5121 01 18 7137053
2022/2023220 271939 2221 020 3251151
Totale 1046